2022 / 05

Next Paper
DOI: 10.24075/brsmu.2022.049

METHOD

Methodology of determining the metabolomic profile of tumor-associated macrophages and monocytes in oncological diseases

Frankevich VE1,2,3, Novoselova AV1, Starodubtseva NL1, Patysheva MR2,4, Larionova IV2,3,4, Rakina MA2, Bragina OD4, Kzhyshkowska JG2,3,5,6
About authors

1 Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia

2 Laboratory of translational cellular and molecular biomedicine, National Research Tomsk State University, Tomsk, Russia

3 Laboratory of Genetic Technologies, Siberian State Medical University, Tomsk, Russia

4 Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia

5 Institute of Transfusion Medicine and Immunology, MI3, Mannheim Faculty of Medicine, University of Heidelberg, Germany

6 German Red Cross Blood Service Baden-Württemberg–Hessen, Mannheim, Germany

Correspondence should be addressed: Vladimir E. Frankevich
Akademika Oparina, 4, Moscow, 117997, Russia; moc.liamg@hciveknarfv

About paper

Funding: the study was financially supported by the Russian Federation represented by the Ministry of Science and Higher Education of the Russian Federation (agreement dated 29 September 2021 № 075-15-2021-1073 on the topic "Genetic and epigenetic editing of tumor cells and the microenvironment in order to block metastasis ").

Author contribution: Frankevich VE, Kzhyshkowska JG — study planning and coordination, manuscript writing; Bragina OD — cancer patient selection and clinical characteristic preparation; Novoselova AV — sample preparation, HPLC-MS/MS; Larionova IV, Patysheva MR — monocyte and macrophage sample preparation and characterization, model TAM system set-up; Rakina MA — obtaining conditioned media of breast cancer cell lines; Starodubtseva NL — HPLC-MS/MS data analysis, manuscript writing; Frankevich VE, Larionova IV, Patysheva MR — discussion of results; Frankevich VE, Kzhyshkowska JG, Starodubtseva NL — manuscript editing.

Compliance with ethical standards: the study was approved by ethical review board of the Federal State Budgetary Educational Institution of Higher Education of the Siberian State Medical University of the Ministry of Health of Russia (protocol № 7 of 14 January 2017), federal laws of the Russian Federation (№ 152, 323, and others), and the 1964 Declaration of Helsinki.

Received: 2022-08-22 Accepted: 2022-09-13 Published online: 2022-10-13
|
  1. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disabilityadjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017; 3: 524–48.
  2. Riabov V, Gudima A, Wang N, Mickley A, Orekhov A, Kzhyshkowska J. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol. 2014; 5 (75).
  3. Lewis CE, Harney AS, Pollard JW. The multifaceted role of perivascular macrophages in tumors. Cancer Cell. 2016; 30: 18–25.
  4. Larionova I, Kazakova E, Gerashchenko T, Kzhyshkowska J. New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis. Cancers. 2021; 13: 3253.
  5. Riabov V, Yin S, Song B, Avdic A, Schledzewski K, Ovsiy I, et al. Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary adenocarcinoma mouse model. Oncotarget. 2016; 7: 31097.
  6. Larionova I, Tuguzbaeva G, Ponomaryova A, Stakheyeva M, Cherdyntseva N, Pavlov V, Choinzonov E and Kzhyshkowska J Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers. Front Oncol. 2020; 10: 566511.
  7. Ding M, Fu X, Tan H, Wang R, Chen Z, Ding S. The effect of vascular endothelial growth factor C expression in tumorassociated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer. Mol Med Rep. 2012; 6: 1023–9.
  8. Mitrofanova I, Zavyalova M, Telegina N, Buldakov M, Riabov V, Cherdyntseva N, et al. Tumor-associated macrophages in human breast cancer parenchyma negatively correlate with lymphatic metastasis after neoadjuvant chemotherapy. Immunobiology. 2017; 222: 101–9.
  9. Rhee I. Diverse macrophages polarization in tumor microenvironment. Arch Pharm Res. 2016; 39: 1588–96.
  10. Liu T, Larionova I, Litviakov N, Riabov V, Zavyalova M, Tsyganov M, et al. Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy. Oncoimmunology. 2018; 7 (6): e1436922.
  11. Larionova I, Kazakova E, Patysheva M, Kzhyshkowska J. Transcriptional, Epigenetic and Metabolic Programming of TumorAssociated Macrophages. Cancers. 2020; 12 (6): 1411.
  12. Larionova I, Cherdyntseva N, Liu T, Patysheva M, Rakina M, Kzhyshkowska J. Interaction of tumor-associated macrophages and cancer chemotherapy. Oncoimmunology. 2019; 8 (7): e1596004.
  13. Riabov V, Salazar F, Htwe SS, Gudima A, Schmuttermaier C, Barthes J, et al. Generation of anti-inflammatory macrophages for implants and regenerative medicine using self-standing release systems with a phenotype-fixing cytokine cocktail formulation. Acta biomaterialia. 2017; 53: 389–98.
  14. Nguyen A, Rudge SA, Zhang Q, Wakelam MJ. Using lipidomics analysis to determine signalling and metabolic changes in cells. Curr Opin Biotechnol. 2017; 43: 96–103.
  15. Cífková E, Holčapek M, Lísa M, Vrána D, Gatěk J, Melichar B. Determination of lipidomic differences between human breast cancer and surrounding normal tissues using HILIC-HPLC/ESIMS and multivariate data analysis. Anal Bioanal Chem. 2015; 407 (3): 991–1002.
  16. Folch J. Simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957; 226 (1): 497–509.
  17. Husen P, Tarasov K, Katafiasz M, Sokol E, Vogt J, Baumgart J, et al. Analysis of Lipid Experiments (ALEX): A Software Framework for Analysis of High-Resolution Shotgun Lipidomics Data. PLoS One. 2013; 8 (11): e79736.
  18. Cifkova E, Holcapek M, Lisa M. Nontargeted lipidomic characterization of porcine organs using hydrophilic interaction liquid chromatography and off-line two-dimensional liquid chromatography-electrospray ionization mass spectrometry. Lipids. 2013; 48 (9): 915–28.
  19. Li M, Yang L, Bai Y, Liu H. Analytical Methods in Lipidomics and Their Applications. Anal Chem. 2014; 86 (1): 161–75.
  20. Koelmel JP, Kroeger NM, Ulmer CZ, Bowden JA, Patterson RE, Cochran JA, et al. LipidMatch: An automated workflow for rulebased lipid identification using untargeted high-resolution tandem mass spectrometry data. BMC Bioinformatics. 2017; 18 (1): 1–11.
  21. Tokareva AO, Chagovec VV, Kononixin AS, Starodubceva NL, Frankevich VE, Nikolaev EN. Algoritm obrabotki massspektrometricheskix dannyx dlya polucheniya diagnosticheskoj paneli molekulyarnyx soedinenij na primere poiska markerov metastazirovaniya pri rake molochnoj zhelezy. Biomedical Chemistry: Research and Methods. 2021; 4 (3): e00156. Russian.
  22. Tokareva AO, Chagovets VV, Kononikhin AS, Starodubtseva NL, Nikolaev EN, Frankevich VE. Normalization methods for reducing interbatch effect without quality control samples in liquid chromatography-mass spectrometry-based studies. Anal Bioanal Chem. 2021; 413 (13): 3479–86.
  23. Tokareva AO, Chagovets VV, Starodubtseva NL, Nazarova NM, Nekrasova ME, Kononikhin AS, et al. Feature selection for OPLSDA discriminant analysis of cancer tissue lipidomics data. JMS. 2019; 55 (1): e4457.
  24. Han X, Yang J, Cheng H, Yang K, Abendschein DR, Gross RW. Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction. Biochemistry. 2005; 44 (50): 16684–94.